Device Trial Radar · NCT07228416
Milky Way Sensor Motion Validation
Last checked: Nov 20, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Feb 5, 2026
Primary completion
Feb 25, 2026
Study completion Feb 25, 2026
Sponsor
- Lead sponsor
- ivWatch, LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 14, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A single arm study of 20 adult volunteers to assess the safety and efficacy of the ivWatch sensors when observing non-infiltrated (normal) tissues at common peripheral IV therapy sites.
Conditions
- Infiltration of Peripheral IV Therapy
Interventions
ivWatch Model 400Device
The ivWatch Model 400 monitored tissue at common IV sites over a 24 hour period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Red Check IV Notification Rate Per DayTime frame: 24 Hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ivWatch LLC
Newport News, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.